/LHDX

LHDX Stock - Lucira Health, Inc.

Q: What is the analyst price target for LHDX?

Analyst price target information is not currently available for LHDX.

Q: What is LHDX's market cap?

Market capitalization information is not currently available for LHDX.

Healthcare|Medical - Devices|NASDAQ

$0.45+0.00%

+$0.00 (+0.00%) • Mar 3

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.50

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for LHDX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2019

FY2020

FY2021

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta3.76

52W High$4.35

52W Low$0.11

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020	FY2019	FY2018
Revenue	$93.06M	$269,000	N/A	N/A
Gross Profit	$10.22M	$-1,672,000	N/A	N/A
Gross Margin	11.0%	-621.6%	N/A	N/A
Operating Income	$-64,540,000	$-31,925,000	$-13,858,000	$-9,815,000
Net Income	$-64,827,000	$-37,401,000	$-8,557,000	$-6,726,000
Net Margin	-69.7%	-13903.7%	N/A	N/A
EPS	$-1.86	$-1.04	$-0.56	$-0.44

Company Overview

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.

Visit Website

Earnings History & Surprises

LHDX

Beat Rate

50%

Last 8 quarters

Avg Surprise

-22.6%

EPS vs Estimate

Beats / Misses

4/4

Last 12 quarters

Latest EPS

$-0.03

Q1 2023

EPS Surprise History

Q2 21

-63.6%

$-0.54vs$-0.33

Q3 21

-18.8%

$-0.38vs$-0.32

Q4 21

+7.8%

$-0.47vs$-0.51

Q1 22

+101.8%

$0.01vs$-0.55

Q2 22

+487.5%

$0.31vs$-0.08

Q3 22

-58.8%

$-0.54vs$-0.34

Q4 22

-728.9%

$-3.15vs$-0.38

Q1 23

+92.5%

$-0.03vs$-0.40

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2023	May 10, 2023	$-0.40	—	—	—
Q1 2023	Mar 10, 2023	$-0.40	$-0.03	+92.5%	✓ BEAT
Q4 2022	Nov 14, 2022	$-0.38	$-3.15	-728.9%	✗ MISS
Q3 2022	Aug 15, 2022	$-0.34	$-0.54	-58.8%	✗ MISS
Q2 2022	May 12, 2022	$-0.08	$0.31	+487.5%	✓ BEAT
Q1 2022	Mar 10, 2022	$-0.55	$0.01	+101.8%	✓ BEAT
Q4 2021	Nov 11, 2021	$-0.51	$-0.47	+7.8%	✓ BEAT
Q3 2021	Aug 12, 2021	$-0.32	$-0.38	-18.8%	✗ MISS
Q2 2021	May 13, 2021	$-0.33	$-0.54	-63.6%	✗ MISS
Q1 2021	Feb 5, 2021	—	$-0.26	—	—
Q3 2020	Sep 30, 2020	—	$-0.77	—	—
Q2 2020	Jun 30, 2020	—	$-0.43	—	—
Q1 2020	Mar 31, 2020	—	$-0.11	—	—
Q4 2019	Dec 31, 2019	—	$-0.14	—	—

Frequently Asked Questions about LHDX

What is LHDX's current stock price?

Lucira Health, Inc. (LHDX) is currently trading at $0.45 per share. The stock has moved +0.00% today.

What is the analyst price target for LHDX?

No analyst price targets are currently available for this stock.

What sector is Lucira Health, Inc. in?

Lucira Health, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.

What is LHDX's market cap?

Lucira Health, Inc. has a market capitalization of $0.02 billion, making it a small-cap company.

Does LHDX pay dividends?

No, Lucira Health, Inc. does not currently pay a dividend to shareholders.